Please provide your email address to receive an email when new articles are posted on . At week 28, 88% of patients treated with combination therapy achieved 75% disease severity reduction vs. 47% on ...

Dear Anon.: Nobody knows what causes lichen planus, an uncommon (less than 1% of people) skin condition that may also affect the mouth or vagina. It most often occurs during the ages of 30 to 60. It ...

Oral Lichen Planus: Causes, Symptoms, Treatment, and Prevention: By Anjali Srivastava Oral Lichen Planus is a long-term inflammatory condition that affects the soft tissues inside the mouth, often ...

Lichen planus (LP) affects an estimated 0.15% of US adults, and more than half of patients do not receive treatment within a year of diagnosis by a dermatologist. To evaluate the prevalence of LP, ...

Low-level light therapy (LLLT) may be a more effective treatment for oral lichen planus (OLP) than topical corticosteroids, according to a review study recently published in the Journal of ...

PITTSBURGH, April 23, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (LIPO) ("Lipella," "we," "our," or the "Company"), a clinical-stage biotechnology company focused on developing therapies ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...

Lichen planus is more of a chronic discomfort than a serious health concern. However, people with the oral form have a slightly higher risk of developing oral cancer. Lichen planus is a group of ...

LP-310 shows significant improvements in pain and inflammation for oral lichen planus, with favorable safety results in Phase 2a trial. Lipella Pharmaceuticals has announced promising results from its ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited ...

No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available PITTSBURGH, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (LIPO) has ...